All terms
CommercializationHospital Buyer & Reimbursement
Advisory Board
Convening of external experts to advise on strategy or product.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
MedTech advisory boards bring together clinicians, scientists, and other experts to advise on product development, clinical strategy, market access, and commercial execution. Subject to Sunshine Act reporting and AdvaMed Code constraints. Boards bring outside experts together to give input on design, trials, reimbursement or strategy. Members are paid fair market value under written agreements with clear deliverables. Compliance teams check that meetings serve a real business need and are not disguised inducements. What the regulation says
Advisory boards, when structured to gather expert opinions on product development or clinical strategies, are generally considered permissible by regulatory bodies like the FDA, provided they adhere to anti-kickback statutes and fair market value compensation guidelines. The AdvaMed Code of Ethics, though not a regulation, outlines industry best practices for engagements with healthcare professionals, emphasizing legitimate purpose and transparent interactions to avoid perceptions of improper influence.What this means in practice
Must be structured around legitimate need, fair-market-value compensation, and documented agendas to avoid anti-kickback risk.Examples
- A MedTech company convenes an advisory board of cardiologists to provide input on the design and clinical testing protocol for a new cardiac stent, ensuring the board’s purpose is clearly defined and documented.
- A medical device manufacturer meticulously tracks and reports all compensation paid to physician advisory board members to comply with the Physician Payments Sunshine Act 42 CFR Part 403, Subpart I reporting requirements.
- Before launching a new surgical robot, a company forms an advisory board of orthopedic surgeons to discuss optimal surgical workflows and user interface improvements, with all interactions transparently recorded.
Common pitfalls
- •Improperly compensated advisory board members can pose a significant anti-kickback risk, leading to potential legal and financial penalties.
- •Advisory boards lacking a clear, documented purpose or agenda may be viewed as a disguised inducement, rather than a legitimate scientific or business activity.
- •Failing to report advisory board compensation and participants as required by regulations such as the Physician Payments Sunshine Act 42 CFR Part 403, Subpart I can result in fines and reputational damage.
- •Advisory boards composed exclusively of individuals with pre-existing commercial interests, lacking diverse and independent expert perspectives, can undermine credibility.
- •Using an advisory board as a sales channel, rather than a genuine forum for expert feedback, can lead to compliance violations and ethical breaches.
Frequently asked questions
The primary regulatory concern revolves around ensuring that advisory boards are legitimate activities for gathering expert advice and not disguised remuneration for past or future business, which could violate anti-kickback statutes.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Commercialization
· Same categoryCommercialization
AdvaMed Code of Ethics
Industry code governing interactions between U.S. medical-device companies and healthcare professionals.
Commercialization
Anti-Kickback Statute(AKS)
U.S. criminal statute prohibiting remuneration to induce federal healthcare business.
Commercialization
Bottom-Up Market Sizing
Building market size from procedure volumes × price × penetration.
Commercialization
Distributor vs Direct Sales
Choice between selling through third-party distributors or hiring a direct salesforce.
Cited by
Where this term appears across MedTech Terms.
Ecosystems (1)
Sources
3 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 2
Link health: 3 verified· last checked 2026-06-20· added official documents checked 2026-11-01
AdvaMed·1AHRMM·1HHS OIG·1
- 1AdvaMed Code of EthicsTier 4 VerifiedAdvaMedadvamed.org
- 2AHRMM - Healthcare Supply ChainTier 4 VerifiedAHRMMahrmm.org
- 3Fraud & Abuse LawsTier 2 VerifiedHHS OIGoig.hhs.gov
Inline markers like [1] jump to the matching reference above.